Energem Corp. (ENCP) Tweaks Lock-Ups for Graphjet Deal
by Nicholas Alan Clayton on 2023-09-07 at 10:38am

Energem Corp. (NASDAQ:ENCP) announced in an 8-K this morning that it has shortened the lock-up for the SPAC’s sponsor while extending it for other parties in the Graphjet combination.

Energem’s sponsor originally was to be locked for one year following close with an early release available only if the combined company traded at or above $12 for 20 of 30 trading days at least 150 days out from close, while company shareholders were all beholden to a six-month lock-up.

Instead, 2,427,908 of the sponsor’s promote shares (84%) will be released from trading restrictions six-months after close, but may be released earlier at a $18 price hurdle under the same conditions. The remaining 447,092 promote shares will be locked for nine months.

Meanwhile, Graphjet investor Suria Sukses Engineering’s 27,600,000 shares and 528,075 shares held by other insiders are to follow the same schedule as the bulk of the promote. Another 2,760,000 held by Graphjet advisor Arc Group and the 107,640,000 shares representing the bulk of the equity compensation to company shareholders will now be locked for nine months.

These will only be released early if the company undergoes a change of control or other major equity reorganization.

The parties originally announced their $1.5 billion combination in August 2022. Kuala Lumpur-based Graphjet processes palm kernel shells into graphene and graphite materials for EV batteries, medical devices and home appliances.

In January, Energem announced it has agreed to a standby equity agreement with Yorkville Advisors Global for it to purchase up to $200 million in newly-issued Graphjet shares priced at either 96% of their one-day VWAP or 97% of the three-day VWAP.

Energem Corp. (ENCP) Tweaks Lock-Ups for Graphjet Deal
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

by Henrique Santa Rosa, CFA on 2025-07-01 at 11:09am

In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...

by Kristi Marvin on 2025-07-01 at 8:42am

An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...

by Nicholas Alan Clayton on 2025-07-01 at 8:25am

At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...

by Nicholas Alan Clayton on 2025-06-30 at 9:04pm

NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved